病例报告:在一只狗中服用里瓦洛克萨班后出现严重的肝病变
Allison P Mosichuk1, Candace Wimbish1, Kristen Poplawski1
1Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, United States.
Frontiers in veterinary science
|April 19, 2024
概括
利瓦罗克萨班是一种抗凝剂,可能会导致狗的肝损伤,类似于人类. 建议对服用这种药物的狗进行更密切的监测,以早期检测潜在的肝毒性.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 里瓦罗克萨班是一种广泛使用的抗凝剂和直接的XA因子抑制剂.
- 人类里瓦洛克萨班诱导的肝毒性病例已被记录.
- 在兽医中以前没有报告过肝毒性,特别是在狗身上.
研究的目的:
- 在rivaroxaban给药后,报告一只狗发生严重肝病的病例.
- 为了突出狗狗里瓦洛克萨班诱导的肝损伤的潜力.
- 倡导加强对接受XA因子抑制剂的狗的监测.
主要方法:
- 一个病例报告,是一只6岁的消毒的雌性混血犬,因肺动脉血栓而接受了里瓦洛克萨班治疗.
- 临床症状监测 (厌食症,昏迷),实验室诊断 (肝酶) 和肝细胞学.
- 停止利瓦罗克萨班治疗并评估临床改善.
主要成果:
- 在开始服用里瓦洛克萨班9天后,这只狗出现了厌食症和昏迷症.
- 通过实验室检查诊断出严重的肝细胞性肝病变.
- 临床症状和肝病变在立即停止使用里瓦罗克萨班后消失,这表明有毒损伤.
- 临床过程反映了人体里瓦洛克萨班诱导的肝毒性病例.
结论:
- 这一案例表明,里瓦罗克萨班可以在狗中引起严重的肝毒性.
- 需要对接受Xa因子抑制剂的狗进行更密切的监测.
- 在疑似肝毒性病例中,应考虑停止利瓦罗克萨班或替代抗凝剂.
更多相关视频
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
3.0K
09:44Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
10.1K
相关概念视频
Drug Toxicity: Risk factors
229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Toxicity Testing in Animals
204
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
204
Hepatic Encephalopathy
53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53
